InsiderClue
Insiders · Profile

TREU JESSE I

Director at Aldeyra Therapeutics · Director at VERACYTE · 10% owner at Vanda Pharmaceuticals. Filing since 12 Dec 2006. CIK 0001013425

ALDX Aldeyra Therapeutics, Inc. Director · 2 trades VCYT VERACYTE, INC. Director · 11 trades VNDA Vanda Pharmaceuticals Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ALDX Aldeyra Therapeutics, Inc.
26 Mar 2019
Director
Sold, plan not stated
96,298
$963.94K
4.9%
ALDX Aldeyra Therapeutics, Inc.
26 Mar 2019
Director
Sold, plan not stated
445
$4.45K
4.8%
VCYT VERACYTE, INC.
4 Mar 2019
Director
Sold, plan not stated
414,958
$8.39M
25.2%
VCYT VERACYTE, INC.
4 Mar 2019
Director
Sold, plan not stated
12,193
$246.42K
100%
VCYT VERACYTE, INC.
1 Mar 2019
Director
Sold, plan not stated
272,977
$5.58M
14.2%
VCYT VERACYTE, INC.
1 Mar 2019
Director
Sold, plan not stated
2,023
$41.37K
14.2%
VCYT VERACYTE, INC.
28 Feb 2019
Director
Sold, plan not stated
347,412
$7.12M
15.3%
VCYT VERACYTE, INC.
28 Feb 2019
Director
Sold, plan not stated
2,588
$53.06K
15.4%
VCYT VERACYTE, INC.
1 Aug 2018
Director
Sold, plan not stated
119,112
$1.29M
5.0%
VCYT VERACYTE, INC.
1 Aug 2018
Director
Sold, plan not stated
888
$9.63K
5.0%
VCYT VERACYTE, INC.
31 Jul 2018
Director
Sold, plan not stated
377,188
$4.08M
13.6%
VCYT VERACYTE, INC.
31 Jul 2018
Director
Sold, plan not stated
2,812
$30.43K
13.7%
VCYT VERACYTE, INC.
16 May 2017
Director
Sold, plan not stated
2,226
$17.99K
9.8%
VNDA Vanda Pharmaceuticals Inc.
12 Dec 2006
10% owner
Sold, plan not stated
12,900
$330.50K
38.0%
14 decisions on file.